NCT02386800
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT02386800
Title CINC424A2X01B Rollover Protocol
Recruitment Active, not recruiting
Gender both
Phase FDA approved
Variant Requirements No
Sponsors Novartis Pharmaceuticals
Indications
Therapies
Age Groups: child | adult | senior
Covered Countries TUR | SWE | POL | LBN | ITA | ISR | HUN | GRC | FRA | ESP | DEU | CAN | BGR | BEL | AUS

Facility Status City State Zip Country Details
Novartis Investigative Site Darlinghurst New South Wales 2010 Australia Details
Novartis Investigative Site Herston Queensland 4029 Australia Details
Novartis Investigative Site Wooloongabba Queensland 4102 Australia Details
Novartis Investigative Site Bedford Park South Australia 5041 Australia Details
Novartis Investigative Site Box Hill Victoria 3128 Australia Details
Novartis Investigative Site Clayton Victoria 3168 Australia Details
Novartis Investigative Site Franston Victoria 3199 Australia Details
Novartis Investigative Site Perth Western Australia 6000 Australia Details
Novartis Investigative Site St Leonards 2065 Australia Details
Novartis Investigative Site Leuven Vlaams Brabant 3000 Belgium Details
Novartis Investigative Site Antwerp 2020 Belgium Details
Novartis Investigative Site Bruges 8000 Belgium Details
Novartis Investigative Site Liège 4000 Belgium Details
Novartis Investigative Site Pleven 5800 Bulgaria Details
Novartis Investigative Site Plovdiv 4002 Bulgaria Details
Novartis Investigative Site Sofia 1431 Bulgaria Details
Novartis Investigative Site Toronto Ontario M5G 1X8 Canada Details
Novartis Investigative Site Viña del Mar Región de Valparaíso 2540364 Chile Details
Novartis Investigative Site Santiago RM 7500922 Chile Details
Novartis Investigative Site Santiago 8420383 Chile Details
Novartis Investigative Site Hangzhou Zhejiang 310003 China Details
Novartis Investigative Site Beijing 100730 China Details
Novartis Investigative Site Paris 75475 France Details
Novartis Investigative Site Dresden Saxony 01307 Germany Details
Novartis Investigative Site Jena Thuringia 07740 Germany Details
Novartis Investigative Site Aachen 52074 Germany Details
Novartis Investigative Site Dresden 01307 Germany Details
Novartis Investigative Site Hamburg 20246 Germany Details
Novartis Investigative Site Magdeburg 39120 Germany Details
Novartis Investigative Site Mainz 55131 Germany Details
Novartis Investigative Site Ulm 89081 Germany Details
Novartis Investigative Site Athens 115 27 Greece Details
Novartis Investigative Site Pátrai 265 04 Greece Details
Novartis Investigative Site Debrecen Hajdu Bihar Megye 4032 Hungary Details
Novartis Investigative Site Budapest H-1097 Hungary Details
Novartis Investigative Site Kaposvár 7400 Hungary Details
Novartis Investigative Site Kecskemét 6001 Hungary Details
Novartis Investigative Site Szeged H 6725 Hungary Details
Novartis Investigative Site Szombathely H-9700 Hungary Details
Novartis Investigative Site Pune Maharashtra 411004 India Details
Novartis Investigative Site Afula 1834111 Israel Details
Novartis Investigative Site Jerusalem 9112001 Israel Details
Novartis Investigative Site Ancona AN 60126 Italy Details
Novartis Investigative Site Bari BA 70124 Italy Details
Novartis Investigative Site Bologna BO 40138 Italy Details
Novartis Investigative Site Brescia BS 25123 Italy Details
Novartis Investigative Site San Giovanni Rotondo FG 71013 Italy Details
Novartis Investigative Site Florence FI 50134 Italy Details
Novartis Investigative Site Milan MI 20122 Italy Details
Novartis Investigative Site Milan MI 20132 Italy Details
Novartis Investigative Site Milan MI 20162 Italy Details
Novartis Investigative Site Rozzano MI 20089 Italy Details
Novartis Investigative Site Palermo PA 90146 Italy Details
Novartis Investigative Site Pavia PV 27100 Italy Details
Novartis Investigative Site Reggio Calabria RC 89124 Italy Details
Novartis Investigative Site Roma RM 00161 Italy Details
Novartis Investigative Site Orbassano TO 10043 Italy Details
Novartis Investigative Site Varese VA 21100 Italy Details
Novartis Investigative Site Napoli 80138 Italy Details
Novartis Investigative Site Nagoya Aichi-ken 453-8511 Japan Details
Novartis Investigative Site Nagoya Aichi-ken 466 8560 Japan Details
Novartis Investigative Site Fukuoka Fukuoka 812-8582 Japan Details
Novartis Investigative Site Sapporo Hokkaido 060 8648 Japan Details
Novartis Investigative Site Isehara Kanagawa 259-1193 Japan Details
Novartis Investigative Site Suita Osaka 565 0871 Japan Details
Novartis Investigative Site Bunkyo Ku Tokyo 113-8677 Japan Details
Novartis Investigative Site Osaka 545-8586 Japan Details
Novartis Investigative Site Beirut 113-0236 Lebanon Details
Novartis Investigative Site Monterrey Nuevo León 64718 Mexico Details
Novartis Investigative Site Gliwice Silesian Voivodeship 44-101 Poland Details
Novartis Investigative Site Wroclaw 50 367 Poland Details
Novartis Investigative Site Lisbon 1099-023 Portugal Details
Novartis Investigative Site Lisbon 1649-035 Portugal Details
Novartis Investigative Site Moscow 125167 Russia Details
Novartis Investigative Site Moscow 125284 Russia Details
Novartis Investigative Site Moscow 129110 Russia Details
Novartis Investigative Site Petrozavodsk 185019 Russia Details
Novartis Investigative Site Saint Petersburg 197022 Russia Details
Novartis Investigative Site Pretoria Gauteng 0181 South Africa Details
Novartis Investigative Site Soweto Gauteng 2013 South Africa Details
Novartis Investigative Site Cape Town Western 7800 South Africa Details
Novartis Investigative Site Pretoria 0027 South Africa Details
Novartis Investigative Site Seoul Korea 03080 South Korea Details
Novartis Investigative Site Seoul 03722 South Korea Details
Novartis Investigative Site Seoul 06591 South Korea Details
Novartis Investigative Site Salamanca Castille and León 37007 Spain Details
Novartis Investigative Site Barcelona Catalonia 08003 Spain Details
Novartis Investigative Site Pamplona Navarre 31008 Spain Details
Novartis Investigative Site Huddinge SE-14186 Sweden Details
Novartis Investigative Site Luleå SE 971 80 Sweden Details
Novartis Investigative Site Lund SE-221 85 Sweden Details
Novartis Investigative Site Uddevalla 451 80 Sweden Details
Novartis Investigative Site Bangkok 10700 Thailand Details
Novartis Investigative Site Istanbul Fatih 34093 Turkey (Türkiye) Details
Novartis Investigative Site Kayseri Melikgazi 38039 Turkey (Türkiye) Details
Novartis Investigative Site Ankara Sihhiye-Altindag 06230 Turkey (Türkiye) Details
Novartis Investigative Site Izmir 35100 Turkey (Türkiye) Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field